Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
BioNTech SE ADR rises Friday, still underperforms market | news.google.com • |
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology | reuters.com • |
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 | globenewswire.com • |
The 3 Best Bargain Stocks to Buy in Q2 2024 | investorplace.com • |
3 Biotech Stocks to Buy for the Next Bull Run: March 2024 | investorplace.com • |
BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions | seekingalpha.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-06 | 2024-03 | -0.41 | N/A | N/A | N/A |
2024-03-20 | 2023-12 | 2.64 | 2.05 | -0.59 | -22.35% |
2023-11-06 | 2023-09 | -0.53 | 0.73 | 1.26 | 237.74% |
2023-11-06 | 2023-09 | -0.53 | N/A | N/A | N/A |
2023-08-07 | 2023-06 | -0.75 | -0.86 | -0.11 | -14.67% |
2023-08-07 | 2023-06 | -0.75 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-16 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-15 | HSBC | Downgrade | Buy | Hold |
2023-08-27 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-07 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-07-31 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 7.45M | 804.11M | 3.11% |
2023-06-29 | Primecap Management Company | 4.66M | 502.94M | 1.94% |
2023-06-29 | Temasek Holdings (Private) Limited | 4.52M | 487.64M | 1.88% |
2023-06-29 | Flossbach von Storch AG | 3.44M | 371.47M | 1.44% |
2023-06-29 | Artisan Partners Limited Partnership | 2.03M | 219.13M | 0.85% |
2023-06-29 | Blackrock Inc. | 1.73M | 186.84M | 0.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Horizon Fund-Capital Opportunity Fund | 2.23M | 241.18M | 0.93% |
2023-07-30 | Primecap Odyssey Aggressive Growth Fund | 1.37M | 149.11M | 0.57% |
2023-08-30 | iShares NASDAQ Biotechnology ETF | 1.37M | 165.80M | 0.57% |
2023-09-29 | New Perspective Fund Inc | 800.00K | 86.91M | 0.33% |
2023-09-29 | First Trust NYSE Arca Biotechnology Index Fund | 416.94K | 45.30M | 0.17% |
2023-06-29 | Artisan Mid-Cap Fund | 375.33K | 40.51M | 0.16% |
Dividend | Date |
---|---|
3.068 | 2022-06-02 |
-
Holding like Big Papa.!
-
Today we going to leave in the underground.....!
-
Living in the underworld jajajajajaja!
-
Deep deep and to the underworld.
-
No shit booooommmmmm
-
OMG it’s no happening
-
- Coronavirus
The US Department of Health and Human Services and Department of Defense have reached a $1.95 billion agreement with the drug company Pfizer to produce at least 100 million doses of a Covid-19 vaccine. Depending on when one is made available, the doses could start shipping out as early as the last quarter of this year. However, there are still myriad questions about how a potential vaccine will be distributed. It can't come too soon, though. The US just recorded its second straight day with more than a thousand Covid-19 deaths. South Korea has fallen into a recession, and Australia has announced its economy has been severely damaged by the pandemic. Oh, and if you're in Ohio, it's time to mask up: A statewide mask mandate goes into effect today.
-
-
-
-
Taking profit now, this will be back to continues down again next week.
-
Taking profit now, this is going down everyday. I will put more on AYTU and IBIO where playing up and down and possibility of going up if not today maybe tomorrow or next week.
-
BioNTech SE ADR rises Friday, still underperforms market
news.google.com • -
The 3 Best Bargain Stocks to Buy in Q2 2024
investorplace.com • -
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
investorplace.com • -
BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions
seekingalpha.com • -
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
investorplace.com • -
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
investorplace.com • -
It's Time! 3 Dodgy Pharma Stocks to Sell in February
investorplace.com • -
3 Pharma Stocks to Sell in February Before They Crash and Burn
investorplace.com • -
Top 10 stocks to buy in 2024
invezz.com • -
BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics
seekingalpha.com • -
BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline
seekingalpha.com • -
Barron's Favorite 10 Stocks for 2024
barrons.com • -
BioNTech Vs. Moderna: Navigating The mRNA Landscape
seekingalpha.com • -
3 Biotech Stocks You'll Regret Not Buying Soon: November 2023
investorplace.com • -
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
investorplace.com • -
BioNTech SE (BNTX) Q3 2023 Earnings Call Transcript
seekingalpha.com • -
Tesla, Organigram, BioNTech, Dish, Bumble, FreshPet, Berkshire Hathaway – Stocks on the move
proactiveinvestors.com • -
BioNTech slashes revenue outlook amid lower Covid vaccine sales
proactiveinvestors.com • -
7 Undervalued Stocks That Analysts Love Right Now
investorplace.com • -
Is BioNTech Stock a Buy Now?
fool.com • -
7 Stocks That Are Heading for a Train Wreck
investorplace.com • -
Pfizer and BioNtech take big write-downs on Covid jab stocks
proactiveinvestors.co.uk • -
7 Innovator Stocks Primed for Exceptional Growth
investorplace.com • -
German court suspends mRNA patent trial against BioNTech
reuters.com • -
US FDA authorizes updated COVID vaccines
reuters.com • -
3 Stocks to Buy For the COVID Resurgence
marketbeat.com • -
UK joins EU in approving XBB.1.5 jab from Pfizer-BioNTech, but others subvariants are emerging
proactiveinvestors.co.uk • -
BioNTech: Not Just Another Jab In The Arm
seekingalpha.com • -
Covid Hospitalizations Jump. So Could Vaccine Demand.
barrons.com • -
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
investorplace.com • -
Why BioNTech Stock Was Sinking Today
fool.com • -
BioNTech SE (BNTX) Q2 2023 Earnings Call Transcript
seekingalpha.com • -
BioNTech Revenue Plunges on Falling Demand for COVID-19 Vaccines
investopedia.com • -
Biotech Stock Hits 2-Year Low as Vaccine Sales Decline
schaeffersresearch.com • -
BioNTech stock declines as revenue topples on lower demand for Covid vaccine
proactiveinvestors.com • -
Disney, UPS, and More Stocks to Watch This Week
barrons.com • -
BioNTech: Unraveling A Bargain, A Hidden Opportunity In Market Misjudgments
seekingalpha.com • -
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
investorplace.com • -
New Strong Buy Stocks for July 11th
zacks.com • -
3 Ugly Stocks That Actually Hide Beautiful Potential
investorplace.com • -
Why Shares of BioNTech Rose Friday
fool.com • -
7 Deeply Undervalued Growth Stocks to Buy in June
investorplace.com • -
7 Safe Stocks to Buy for an Economic Downward Spiral
investorplace.com • -
BioNTech: Hold Out For More Data (Rating Downgrade)
seekingalpha.com • -
BioNTech braces for weak Q2 as Covid vaccine demand subsides
proactiveinvestors.com • -
BioNTech reports strong 1Q earnings; expands focus beyond Covid-19 vaccines
proactiveinvestors.com • -
Earnings Previews: BioNTech, Tyson Foods, Warner Bros Discovery
247wallst.com •